Boston Scientific Corp (BSX) 24.17 $BSX
Boston Scientific To Participate In Canaccord Genuity Growth Conference And Wedbush PacGrow Healthcare Conference
PR Newswire - Mon Aug 01, 7:30AM CDT
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 36th Annual Canaccord Genuity Growth Conference on August 11 in Boston and the 2016 Wedbush PacGrow Healthcare Conference on August 16 in New York.
BSX: 24.17 (-0.26)
Ford and Whole Foods skid, Alere and Facebook jump
AP - Thu Jul 28, 3:39PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:
BSX: 24.17 (-0.26), WFM: 30.16 (-0.25), F: 11.94 (-0.54), FB: 123.09 (-1.22), ALR: 36.59 (-0.38), GRPN: 5.10 (+0.11), MOH: 57.02 (+0.86)
Boston Scientific (BSX) Meets Q2 Earnings Estimate, Views Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:03PM CDT
Boston Scientific Corporation (BSX) announced adjusted EPS of 27 cents in the second quarter of 2016, up 22.7% from the year-ago quarter.
BSX: 24.17 (-0.26), GWPH: 94.07 (-2.04), BAX: 48.48 (-0.02), VASC: 45.35 (-1.10)
Boston Scientific posts strong sales and boosts its outlook
AP - Thu Jul 28, 12:37PM CDT
NEW YORK (AP) — Boston Scientific's stock traded higher Thursday after the medical device maker reported better-than-expected second-quarter sales and raised its forecasts for the year.
BSX: 24.17 (-0.26)
Boston Scientific (BSX) Breaks Through Resistance at $24.01
Comtex SmarTrend(R) - Thu Jul 28, 9:20AM CDT
Shares of Boston Scientific (NYSE:BSX) opened today above their pivot of $23.76 and have already reached the first level of resistance at $24.01. Analysts will be watching for a cross of the next upside pivot targets of $24.35 and $24.94.
BSX: 24.17 (-0.26)
Boston Scientific (BSX) Posts In-Line Q2 Earnings, View Up
Aparajita Dutta - Zacks Investment Research - Thu Jul 28, 7:19AM CDT
Boston Scientific's (BSX) adjusted earnings of 27 cents per share came in line with the Zacks Consensus estimate.
BSX: 24.17 (-0.26)
Boston Scientific Announces Results For Second Quarter 2016
PR Newswire - Thu Jul 28, 5:30AM CDT
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.126 billion during the second quarter ended June 30, 2016, compared to the company's guidance range for the quarter of $2.010 to $2.060 billion. This represents growth of 15 percent on a reported basis and 16 percent on an operational basis (calculated on a constant currency basis), all compared to the prior year period. The company reported a GAAP loss of $207 million, or $(0.15) per share, compared to earnings of $0.08 a year ago, and achieved adjusted earnings per share of $0.27 for the period, compared to $0.22 a year ago.
BSX: 24.17 (-0.26)
Shares of BSX Up 31.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 28, 12:44AM CDT
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on March 14th, 2016 at $18.01. In approximately 5 months, Boston Scientific has returned 31.41% as of today's recent price of $23.66.
BSX: 24.17 (-0.26)
After Yesterday's Decline of 1.61%, Boston Scientific Offers Investors Better Value
Comtex SmarTrend(R) - Wed Jul 27, 2:32PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $23.53 to a high of $24.11. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $23.62 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BSX: 24.17 (-0.26)
NuVasive (NUVA) Beats on Q2 Earnings, Raises FY16 View
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:27PM CDT
NuVasive, Inc. (NUVA) reported second-quarter 2016 adjusted earnings per share (EPS) of 40 cents, reflecting a 29% rise from the year-ago quarter.
BSX: 24.17 (-0.26), ZBH: 130.59 (-0.47), GWPH: 94.07 (-2.04), NUVA: 62.63 (-0.66)
C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:19PM CDT
C.R. Bard Inc. (BCR) reported adjusted earnings of $2.56 in the second quarter of 2016, exceeding the Zacks Consensus Estimate by a dime.
HYH: 33.84 (-0.23), BSX: 24.17 (-0.26), BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69)
Boston Scientific Announces Acquisition of Cosman Medical
PR Newswire - Wed Jul 27, 8:00AM CDT
Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired Cosman Medical, Inc., a privately held Burlington, Mass. manufacturer of radiofrequency ablation (RFA) systems. The Cosman Medical team and products will become part of the Boston Scientific Neuromodulation business, which offers a range of Spinal Cord Stimulator (SCS) systems to treat patients with chronic pain, and Deep Brain Stimulation systems* for the treatment of Parkinson's disease, dystonia and essential tremor.
BSX: 24.17 (-0.26)
Look at Medical Product Earnings on Jul 28: BSX, RMD & More
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:59AM CDT
Medical is one of the seven broader sectors among the 16 Zacks sectors to report earnings growth this season.
BSX: 24.17 (-0.26), SRDX: 27.69 (+0.63), ZBH: 130.59 (-0.47), VIVO: 19.29 (-0.26), RMD: 69.38 (-0.47)
PetMed (PETS) Tops Q1 Earnings, Lags Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 1:08PM CDT
PetMed Express, Inc. (PET) announced earnings per share (EPS) of 32 cents in the first quarter of fiscal 2017, up 10.3% from the year-ago quarter.
BSX: 24.17 (-0.26), STMP: 77.35 (-0.78), EVLV: 1.89 (-0.03)
Chemed (CHE) Lags Q2 Earnings, Tops Revenues, View Up
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:59AM CDT
Chemed???s (CHE) second-quarter 2016 results were a mixed bag with its bottom-line lagging behind the Zacks Consensus Estimate while revenues exceeded the same
CHE: 145.13 (-1.94), BSX: 24.17 (-0.26), NUVA: 62.63 (-0.66)
Baxter International (BAX) Q2 Earnings, Sales Top; View Up
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 8:25AM CDT
Baxter International Inc (BAX) reported second-quarter 2016 adjusted earnings of 46 cents per share, which surpassed the Zacks Consensus Estimate by 7 cents.
BSX: 24.17 (-0.26), BAX: 48.48 (-0.02), BXLT: 46.02 (-0.18), NUVA: 62.63 (-0.66)
Alere Updates on 10K Filing, Reports Preliminary Q1 Figures
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:24PM CDT
Alere Inc. (ALR) lowered revenue estimate for the year that ended on Dec 31, 2015 and also offered some Q1 figures.
BSX: 24.17 (-0.26), ABT: 45.07 (-0.22), ALR: 36.59 (-0.38), NUVA: 62.63 (-0.66)
Will AmSurg's Merger with Envision Healthcare Drive Growth?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:08PM CDT
AmSurg (AMSG) recently agreed to merge in an all-stock deal with Envision Healthcare to create one of the largest providers of physician services in the U.S.
AMSG: 72.04 (-0.19), BSX: 24.17 (-0.26), EVHC: 23.54 (-0.05), GWPH: 94.07 (-2.04), NUVA: 62.63 (-0.66)
Zacks.com featured highlights: J. M. Smucker, Energizer Holdings, Boston Scientific, Tahoe Resources and Owens Corning
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 8:30AM CDT
Zacks.com featured highlights: J. M. Smucker, Energizer Holdings, Boston Scientific, Tahoe Resources and Owens Corning
BSX: 24.17 (-0.26), OC: 53.96 (+0.40), TAHO: 15.66 (-0.04), ENR: 50.94 (-0.99), SJM: 154.58 (+0.30)
Boston Scientific To Participate In Canaccord Genuity Growth Conference And Wedbush PacGrow Healthcare Conference
PR Newswire - Mon Aug 01, 7:30AM CDT
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 36th Annual Canaccord Genuity Growth Conference on August 11 in Boston and the 2016 Wedbush PacGrow Healthcare Conference on August 16 in New York.
BSX: 24.17 (-0.26)
Ford and Whole Foods skid, Alere and Facebook jump
AP - Thu Jul 28, 3:39PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Thursday:
BSX: 24.17 (-0.26), WFM: 30.16 (-0.25), F: 11.94 (-0.54), FB: 123.09 (-1.22), ALR: 36.59 (-0.38), GRPN: 5.10 (+0.11), MOH: 57.02 (+0.86)
Boston Scientific (BSX) Meets Q2 Earnings Estimate, Views Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:03PM CDT
Boston Scientific Corporation (BSX) announced adjusted EPS of 27 cents in the second quarter of 2016, up 22.7% from the year-ago quarter.
BSX: 24.17 (-0.26), GWPH: 94.07 (-2.04), BAX: 48.48 (-0.02), VASC: 45.35 (-1.10)
Boston Scientific posts strong sales and boosts its outlook
AP - Thu Jul 28, 12:37PM CDT
NEW YORK (AP) — Boston Scientific's stock traded higher Thursday after the medical device maker reported better-than-expected second-quarter sales and raised its forecasts for the year.
BSX: 24.17 (-0.26)
Boston Scientific (BSX) Breaks Through Resistance at $24.01
Comtex SmarTrend(R) - Thu Jul 28, 9:20AM CDT
Shares of Boston Scientific (NYSE:BSX) opened today above their pivot of $23.76 and have already reached the first level of resistance at $24.01. Analysts will be watching for a cross of the next upside pivot targets of $24.35 and $24.94.
BSX: 24.17 (-0.26)
Boston Scientific (BSX) Posts In-Line Q2 Earnings, View Up
Aparajita Dutta - Zacks Investment Research - Thu Jul 28, 7:19AM CDT
Boston Scientific's (BSX) adjusted earnings of 27 cents per share came in line with the Zacks Consensus estimate.
BSX: 24.17 (-0.26)
Boston Scientific Announces Results For Second Quarter 2016
PR Newswire - Thu Jul 28, 5:30AM CDT
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.126 billion during the second quarter ended June 30, 2016, compared to the company's guidance range for the quarter of $2.010 to $2.060 billion. This represents growth of 15 percent on a reported basis and 16 percent on an operational basis (calculated on a constant currency basis), all compared to the prior year period. The company reported a GAAP loss of $207 million, or $(0.15) per share, compared to earnings of $0.08 a year ago, and achieved adjusted earnings per share of $0.27 for the period, compared to $0.22 a year ago.
BSX: 24.17 (-0.26)
Shares of BSX Up 31.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 28, 12:44AM CDT
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on March 14th, 2016 at $18.01. In approximately 5 months, Boston Scientific has returned 31.41% as of today's recent price of $23.66.
BSX: 24.17 (-0.26)
After Yesterday's Decline of 1.61%, Boston Scientific Offers Investors Better Value
Comtex SmarTrend(R) - Wed Jul 27, 2:32PM CDT
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $23.53 to a high of $24.11. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $23.62 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BSX: 24.17 (-0.26)
NuVasive (NUVA) Beats on Q2 Earnings, Raises FY16 View
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:27PM CDT
NuVasive, Inc. (NUVA) reported second-quarter 2016 adjusted earnings per share (EPS) of 40 cents, reflecting a 29% rise from the year-ago quarter.
BSX: 24.17 (-0.26), ZBH: 130.59 (-0.47), GWPH: 94.07 (-2.04), NUVA: 62.63 (-0.66)
C.R. Bard (BCR) Beats Q2 Earnings & Sales, FY16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:19PM CDT
C.R. Bard Inc. (BCR) reported adjusted earnings of $2.56 in the second quarter of 2016, exceeding the Zacks Consensus Estimate by a dime.
HYH: 33.84 (-0.23), BSX: 24.17 (-0.26), BCR: 222.63 (-2.52), ALGN: 90.38 (+0.69)
Boston Scientific Announces Acquisition of Cosman Medical
PR Newswire - Wed Jul 27, 8:00AM CDT
Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired Cosman Medical, Inc., a privately held Burlington, Mass. manufacturer of radiofrequency ablation (RFA) systems. The Cosman Medical team and products will become part of the Boston Scientific Neuromodulation business, which offers a range of Spinal Cord Stimulator (SCS) systems to treat patients with chronic pain, and Deep Brain Stimulation systems* for the treatment of Parkinson's disease, dystonia and essential tremor.
BSX: 24.17 (-0.26)
Look at Medical Product Earnings on Jul 28: BSX, RMD & More
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 5:59AM CDT
Medical is one of the seven broader sectors among the 16 Zacks sectors to report earnings growth this season.
BSX: 24.17 (-0.26), SRDX: 27.69 (+0.63), ZBH: 130.59 (-0.47), VIVO: 19.29 (-0.26), RMD: 69.38 (-0.47)
PetMed (PETS) Tops Q1 Earnings, Lags Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 1:08PM CDT
PetMed Express, Inc. (PET) announced earnings per share (EPS) of 32 cents in the first quarter of fiscal 2017, up 10.3% from the year-ago quarter.
BSX: 24.17 (-0.26), STMP: 77.35 (-0.78), EVLV: 1.89 (-0.03)
Chemed (CHE) Lags Q2 Earnings, Tops Revenues, View Up
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:59AM CDT
Chemed???s (CHE) second-quarter 2016 results were a mixed bag with its bottom-line lagging behind the Zacks Consensus Estimate while revenues exceeded the same
CHE: 145.13 (-1.94), BSX: 24.17 (-0.26), NUVA: 62.63 (-0.66)
Baxter International (BAX) Q2 Earnings, Sales Top; View Up
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 8:25AM CDT
Baxter International Inc (BAX) reported second-quarter 2016 adjusted earnings of 46 cents per share, which surpassed the Zacks Consensus Estimate by 7 cents.
BSX: 24.17 (-0.26), BAX: 48.48 (-0.02), BXLT: 46.02 (-0.18), NUVA: 62.63 (-0.66)
Alere Updates on 10K Filing, Reports Preliminary Q1 Figures
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:24PM CDT
Alere Inc. (ALR) lowered revenue estimate for the year that ended on Dec 31, 2015 and also offered some Q1 figures.
BSX: 24.17 (-0.26), ABT: 45.07 (-0.22), ALR: 36.59 (-0.38), NUVA: 62.63 (-0.66)
Will AmSurg's Merger with Envision Healthcare Drive Growth?
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 3:08PM CDT
AmSurg (AMSG) recently agreed to merge in an all-stock deal with Envision Healthcare to create one of the largest providers of physician services in the U.S.
AMSG: 72.04 (-0.19), BSX: 24.17 (-0.26), EVHC: 23.54 (-0.05), GWPH: 94.07 (-2.04), NUVA: 62.63 (-0.66)
Zacks.com featured highlights: J. M. Smucker, Energizer Holdings, Boston Scientific, Tahoe Resources and Owens Corning
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 8:30AM CDT
Zacks.com featured highlights: J. M. Smucker, Energizer Holdings, Boston Scientific, Tahoe Resources and Owens Corning
BSX: 24.17 (-0.26), OC: 53.96 (+0.40), TAHO: 15.66 (-0.04), ENR: 50.94 (-0.99), SJM: 154.58 (+0.30)
